Microultrasonography-guided prostate biopsy proved noninferior to MRI/conventional ultrasound-fusion (MRI/US-fusion) imaging for detecting clinically significant cancer, a large randomized trial ...

September is National Prostate Cancer Awareness Month, an important time to bring awareness to prostate health. The prostate gland is a male reproductive organ about the size of a ping-pong ball that ...

Greater diagnostic accuracy in detecting significant prostate cancer has been reported following a 4-year clinical evaluation at Castle Hill Hospital, part of Hull University Teaching Hospitals NHS ...

FusionVu will be demonstrated at the EAU (European Association of Urology) 2017 Annual Congress in London, UK TORONTO and LONDON, UK, March 23, 2017/PRNewswire/ - Exact Imaging (www.exactimaging.com), ...

Compared with TRUS biopsies, MRI fusion biopsy findings are more likely to be concordant with final prostate cancer pathology at the time of radical prostatectomy, a study found. Prostate biopsies ...

Less than 1% of patients who underwent the procedure under local analgesia and without antibiotic prophylaxis experienced post-biopsy infection, a study found. Transperineal magnetic resonance imaging ...

MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...

Could imaging be used for routine screening for prostate cancer in healthy men — similar to mammography for breast cancer screening? A quick scan — with 15-minute, contrast-free MRI — detected more ...

Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Fifty prostate cancer patients with elevated/increasing serum ...

Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...